Pre-solicitation Notice_75N98026Q01035.pdf

DEPARTMENT OF HEALTH & HUMAN SERVICES National Institutes of Health

Office of the Director (OD) Office of Acquisition and Logistics Management (OALM)

Office of Logistics and Operations (OLAO)

Presolicitation Number: 75N98026Q01035

PRESOLICITATION NOTICE

Presolicitation Number: 75N98026Q01035 Acquisition Title: Illumina DRAGEN GCP Lvl 4 1-year License NAICS Code: 541714 NAICS Size Standard: 1000 – in number of employees PSC Code: 7A21 Procedures: RFO Part 12, Simplified Acquisition Procedures Anticipated award date: 09/30/2026

This Presolicitation notice is NOT a Request for Quotation (RFQ)/Solicitation, however all responsible sources may submit a capability statement, quotation, bid, or proposal, as appropriate, which will be considered by the agency. Responses shall be submitted electronically to Ijada Fields via email to ijada.fields@nih.gov no later than 12:00PM (Eastern Time), 09/10/2026.

Emails must reference Presolicitation Number 75N98026Q01035 in the subject line.

The solicitation:

[X] Will be posted to the Government Point of Entry (GPE): https://sam.gov/ [ ] Will NOT be posted to the Government Point of Entry (GPE)

POINT OF CONTACT

Contracting Officer Name: Ijada Fields Agency/Office: National Institutes of Health Address: 6701 Rockledge Dr, Bethesda, MD 20817 Email: ijada.fields@nih.gov

SET-ASIDE STATUS

[ X ] Not Set-Aside [ ] Total Set-Aside [ ] Partial Set-Aside [ ] Local Area Set-Aside mailto:ijada.fields@nih.gov https://sam.gov/ mailto:ijada.fields@nih.gov

DEPARTMENT OF HEALTH & HUMAN SERVICES National Institutes of Health

Office of Acquisition and Logistics Management (OALM)

Office of Logistics and Operations (OLAO)

Presolicitation Number: 75N98026Q01035

DESCRIPTION OF REQUIREMENT

The National Institute of Neurological Disorders and Stroke (NINDS), Neurodegenerative Diseases Research Section (NDRS), requires a 12-month subscription/access to the Illumina DRAGEN GCP Level 4 platform to process approximately 1,300,000 GB of whole-genome sequencing data derived from 10,000 human genomes. The platform must support graph-based alignment to the human reference genome (hg38), accurate variant calling, and detection of single-nucleotide variants, insertions/deletions, structural variants, copy number variants, and repeat expansions.

The platform must be fully compatible with Illumina-generated sequencing data and existing DRAGEN-processed datasets. The contractor shall provide access and operational availability of the DRAGEN GCP platform and processing capability sufficient to analyze the 10,000 genomes during the 12-month period of performance.

PERFORMANCE / DELIVERY

Place(s) of Delivery/Performance/Acceptance: NINDS Estimated Delivery Date(s)/Period of Performance: 09/30/2026 – 09/29/2027

TRADE AGREEMENTS

Items subject to WTO GPA or a Free Trade Agreement:

[ ] Yes:

[ ] FAR 52.225-3, Buy American–Free Trade Agreements–Israeli Trade Act: “One or more of the items under this acquisition is subject to Free Trade Agreements.”

[ ] FAR 52.225-5, Trade Agreements: “One or more of the items under this acquisition is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements.”

[ ] FAR 52.225-11, Buy American-Construction Materials under Trade Agreements: “One or more of the items under this acquisition is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements.”

[ ] FAR 52.225-23, Required Use of American Iron, Steel, and Manufactured Goods-Buy American Statute-Construction Materials under Trade Agreements: “One or more of the items under this acquisition is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements.”

[ X ] No

[ ] N/A – Unknown

TECHNICAL DATA

Technical data required to respond will be included in solicitation:

[ ] Yes

DEPARTMENT OF HEALTH & HUMAN SERVICES National Institutes of Health

Office of Acquisition and Logistics Management (OALM)

Office of Logistics and Operations (OLAO)

Presolicitation Number: 75N98026Q01035

[ ] No:

Can be obtained: ______________________________________________________

[ X ] N/A – Not Required

SMALL BUSINESS CONSTRUCTION

[ ] Yes:

Include definitization/change order information:

[ X ] No

NONCOMPETITIVE CONTRACT ACTION

[ X ] Yes:

Statutory authority: 41 U.S.C. 1901 Intended Source: Illumina, Inc.

Justification: Pursuant to RFO FAR 12.202, NINDS intends to solicit and award this requirement on a sole-source basis to Illumina, Inc. for access to the proprietary Illumina DRAGEN GCP Level 4 platform. Market research determined that Illumina is the only source reasonably available to meet the Government's requirements. Alternative technologies, including those offered by Thermo Fisher and QIAGEN, do not meet all essential requirements for compatibility, scalability, and DRAGEN-equivalent analysis. The Government's existing Illumina whole-genome sequencing data must be processed on the same DRAGEN platform as previously processed datasets to permit accurate integration and downstream analyses. Accordingly, Illumina, Inc. is the only responsible source identified as capable of satisfying the requirement.

[ ] No

QUALIFICATION REQUIREMENTS

Offeror or product/service must meet a qualification requirement:

[ ] Yes

Qualification Requirement: _____________________________________________________ Qualification may be obtained from: ___________________________________________

[ X ] No